1.
ACG Case Rep J
; 4: e5, 2017.
Article
in English
| MEDLINE
| ID: mdl-28138449
ABSTRACT
Budesonide is the treatment of choice for microscopic colitis because of its excellent risk to benefit ratio. It is a potent, well-absorbed corticosteroid, but because of a high rate of first-pass metabolism in the liver, its systemic bioavailability is low. It has fewer corticosteroid-related adverse effects than prednisone, and adrenal suppression is considered to be rare. We present a middle-aged woman with lymphocytic colitis whose symptoms responded to budesonide but developed budesonide-related iatrogenic Cushing's syndrome. Withdrawal of budesonide led to restoration of normal pituitary-adrenal responsiveness but at the price of recurrent diarrhea due to re-emergence of lymphocytic colitis.
2.
Am J Gastroenterol
; 105(11): 2511-2, 2010 Nov.
Article
in English
| MEDLINE
| ID: mdl-21048694
Subject(s)
Carcinoid Tumor/diagnosis , Ileal Neoplasms/diagnosis , Aged , Carcinoid Tumor/surgery , Colonoscopy , Humans , Ileal Neoplasms/surgery , Middle Aged
3.
Clin Gastroenterol Hepatol
; 7(9): e57, 2009 Sep.
Article
in English
| MEDLINE
| ID: mdl-18691941
Subject(s)
Colitis, Collagenous/diagnosis , Intestinal Mucosa/injuries , Intestinal Mucosa/pathology , Anti-Infective Agents/therapeutic use , Anti-Inflammatory Agents/therapeutic use , Antidiarrheals/therapeutic use , Biopsy , Bismuth/therapeutic use , Budesonide/therapeutic use , Ciprofloxacin/therapeutic use , Colitis, Collagenous/drug therapy , Colitis, Collagenous/pathology , Colonoscopy , Enema , Female , Humans , Metronidazole/therapeutic use , Middle Aged , Organometallic Compounds/therapeutic use , Salicylates/therapeutic use , Treatment Outcome
4.
Am J Gastroenterol
; 103(5): 1314-5, 2008 May.
Article
in English
| MEDLINE
| ID: mdl-18477362